We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+6.23%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$29B
AUM Growth
+$2.89B
(+11%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
5.52%
Top 10 Holdings %
Top 10 Hldgs %
17.32%
Holding
533
New
67
Increased
191
Reduced
199
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$519M |
| 2 |
Pfizer
PFE
|
+$351M |
| 3 |
Eli Lilly
LLY
|
+$212M |
| 4 |
Devon Energy
DVN
|
+$189M |
| 5 |
Cognizant
CTSH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$246M |
| 2 |
US Bancorp
USB
|
+$182M |
| 3 |
Comcast
CMCSA
|
+$118M |
| 4 |
AbbVie
ABBV
|
+$115M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.57% |
| 2 | Technology | 16.55% |
| 3 | Financials | 16.53% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Perrigo
PRGO
$1.4B
| $42.6M | 0.15% |
254,664
+25,588
| +11% | +$4M |
|
|
XLNX
152
DELISTED
Xilinx Inc
XLNX
| $42.4M | 0.15% |
980,174
+888,432
| +968% | +$38.5M |
|
153
Intel
INTC
$466B
| $42.4M | 0.15% |
1,169,195
-136,473
| -10% | -$4.75M |
|
154
Pediatrix Medical
MD
$2.16B
| $42.2M | 0.15% |
638,623
+62,930
| +11% | +$3.84M |
|
155
Illumina
ILMN
$29.4B
| $41.7M | 0.14% |
232,498
+71,499
| +44% | +$12.6M |
|
|
SNDK
156
DELISTED
SANDISK CORP
SNDK
| $41.2M | 0.14% |
420,197
+80,000
| +24% | +$7.65M |
|
157
Aptiv
APTV
$12B
| $40.9M | 0.14% |
562,703
-223,976
| -28% | -$15.4M |
|
158
United Airlines
UAL
$38.4B
| $39.6M | 0.14% |
591,631
+125,013
| +27% | +$6.92M |
|
159
Crown Castle
CCI
$32.7B
| $39.3M | 0.14% |
499,786
+51,402
| +11% | +$4.12M |
|
160
Yum! Brands
YUM
$41B
| $39.3M | 0.14% |
750,834
-1,170
| -0.2% | -$60.9K |
|
|
JOBS
161
DELISTED
51job Inc
JOBS
| $39.3M | 0.14% |
1,096,320
+197,900
| +22% | +$6.6M |
|
162
Abbott
ABT
$180B
| $39M | 0.13% |
866,225
+136,355
| +19% | +$5.94M |
|
163
Bath & Body Works
BBWI
$4.01B
| $38.3M | 0.13% |
548,078
+387,284
| +241% | +$23.9M |
|
164
The Mosaic Company
MOS
$7.09B
| $38M | 0.13% |
832,373
-27,536
| -3% | -$1.22M |
|
165
Dr. Reddy's Laboratories
RDY
$9.82B
| $37.7M | 0.13% |
3,741,255
-4,915,045
| -57% | -$51.7M |
|
166
Danaher
DHR
$135B
| $37.6M | 0.13% |
653,161
+61,083
| +10% | +$3.31M |
|
167
Estee Lauder
EL
$29B
| $37M | 0.13% |
485,602
+17,691
| +4% | +$1.31M |
|
168
Norfolk Southern
NSC
$78.8B
| $36.6M | 0.13% |
333,816
-611,895
| -65% | -$67.1M |
|
169
Jones Lang LaSalle
JLL
$15.1B
| $36.6M | 0.13% |
244,000
+44,000
| +22% | +$6.07M |
|
170
Bausch Health
BHC
$1.65B
| $36M | 0.12% |
251,272
+113,499
| +82% | +$15.3M |
|
171
JD.com
JD
$40.8B
| $35M | 0.12% |
1,513,910
+387,466
| +34% | +$9.55M |
|
|
SPLS
172
DELISTED
Staples Inc
SPLS
| $34.8M | 0.12% |
1,921,965
-1,866
| -0.1% | -$26.1K |
|
173
Meta Platforms (Facebook)
META
$1.51T
| $34.8M | 0.12% |
+445,512
| New | +$34.1M |
|
174
Wells Fargo
WFC
$261B
| $34.6M | 0.12% |
631,148
+244,854
| +63% | +$13M |
|
|
TGNA
175
DELISTED
TEGNA Inc
TGNA
| $34M | 0.12% |
2,038,049
+268,689
| +15% | +$4.33M |
|
Similar funds
Fidelity International's Q4 2014 Portfolio in Review
As of Q4 2014, Fidelity International held 533 positions worth $29B, up 11% from $26.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fidelity International deployed $1.6B of net new capital in Q4 2014, opening 67 new positions and adding to 191 existing holdings. Its largest new stake was UBS Group: 30,316,557 shares worth $521M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Amgen, an estimated $246M trimmed.
- Fidelity International's largest Q4 2014 buy was UBS Group: 30,316,557 shares worth $521M.
- Fidelity International added most to Pfizer in Q4 2014, an estimated $351M increase.
- Fidelity International's biggest Q4 2014 reduction was Amgen, cutting an estimated $246M.
- Fidelity International fully exited Coca-Cola Europacific Partners in Q4 2014, selling an estimated $102M.
- Fidelity International's ten largest holdings make up 17% of its $29B portfolio in Q4 2014.
- Fidelity International opened 67 new positions and closed 55 in Q4 2014.
- Fidelity International's portfolio value rose 11% quarter-over-quarter to $29B.
Based on Fidelity International's 13F filing for Q4 2014, filed 17 Feb 2015.